NMN IV Therapy
NAD+ precursor | Cellular energy metabolism and mitochondrial activation
이 치료에 대해
NMN IV therapy injects nicotinamide mononucleotide (NAD+ precursor) intravenously for anti-aging. NAD+ is essential cofactor for ATP production via mitochondrial electron transport chain. Age-associated NAD+ decline impairs mitochondrial function, reducing energy production.
NMN therapy recovers NAD+, improving mitochondrial ATP efficiency. Simultaneously activates sirtuins (longevity genes), promoting DNA repair, cellular stress response, metabolic improvement. In skin, fibroblast energy metabolism improves, boosting collagen synthesis. Whole-body energy and metabolism improve, achieving skin texture improvement plus systemic rejuvenation.
작용 기전
NMN IV infusion raises blood NAD+ concentration. Transported into mitochondria, functions as cofactor for respiratory chain complexes I-IV. Smooth electron transfer increases ATP production efficiency. Simultaneously activates sirtuins (SIRT1, SIRT3), promoting NAD+-dependent deacetylation. Upregulates DNA repair genes (PARP, BRCA1), improving cellular stress resistance. In skin, collagen synthesis genes upregulate, increasing collagen production alongside improved energy metabolism.
적응증
기대 효과
Post-NMN infusion, fatigue improves at 2-4 weeks. Skin firmness and elasticity improve at 3-6 months. Texture enhances, dullness reduces. Overall energy increases, sleep quality improvement reported. Effects sustained with continued infusions.
임상 근거
위험 및 부작용
IV site pain, swelling. Rarely, transient headache or mild nausea. Individual constitution may have vasculitis risk. Metabolic imbalance with high-dose infusions. Long-term safety data still limited.